
Aino Kalervo
MSc, MS, Chief Operating Officer
Chief Operating Officer, Aino Kalervo, is trained in both molecular biology and business and has over a decade’s experience in the business development of early stage biologics and therapeutic vaccines. Prior to joining TILT, Aino worked at Sanofi’s Paris office and Theravectys, a French therapeutic vaccine company. Aino is responsible for all aspects of business, including fund raising, business development, and bridging the gap from breakthrough science to product success.